AFTPH: A Drug Target / Disease Biomarker (G54812)

Target Name: AFTPH

NCBI ID: G54812

AFTPH

AFTPH: A Drug Target / Disease Biomarker

AFTPH, or alternating current protein, is a protein that is expressed in the brain and is involved in the regulation of muscle movement and posture. It is a key player in the development and maintenance of muscle tone, and is also involved in the regulation of movement and in the control of posture.

One of the unique features of AFTPH is its ability to interact with several different proteins, including the protein known as myosin. Myosin is a protein that is responsible for the contractions of muscles, and is a key player in the regulation of muscle movement.

AFTPH has been shown to play a key role in the regulation of muscle movement and posture, and is a potential drug target for the treatment of a variety of muscle-related conditions. For example, studies have shown thatAFTPH levels are decreased in individuals with certain muscle-related conditions, such as ALS and multiple sclerosis, and that these changes can contribute to the severity of these conditions.

In addition to its role in muscle movement and posture, AFTPH is also involved in the regulation of pain and inflammation. Studies have shown thatAFTPH levels are decreased in individuals with certain types of pain, and that these changes can contribute to the severity of these conditions.

Overall, AFTPH is a protein that is involved in a variety of important processes in the brain and body. Its unique ability to interact with multiple different proteins, including myosin, makes it a promising target for the development of new drugs for the treatment of muscle-related conditions.

Protein Name: Aftiphilin

Functions: Component of clathrin-coated vesicles (PubMed:15758025). Component of the aftiphilin/p200/gamma-synergin complex, which plays roles in AP1G1/AP-1-mediated protein trafficking including the trafficking of transferrin from early to recycling endosomes, and the membrane trafficking of furin and the lysosomal enzyme cathepsin D between the trans-Golgi network (TGN) and endosomes (PubMed:15758025)

The "AFTPH Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about AFTPH comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets